Evidence map›Paper›PMID 40646054›Full record

ArticleScientific reports2025

Multidimensional reference regions is a new tool to optimize the personalized care of patients.

Peggy Gandia, Angélo Faget, Thibaut Jamme, Jérôme Ausseil, Didier Concordet

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Peggy GandiaLaboratoire de Pharmacocinétique et Toxicologie, Institut Fédératif de Biologie, CHU de Toulouse, Toulouse, France. gandia.p@chu-toulouse.fr.
Angélo FagetINTHERES, Université de Toulouse, INRAE, ENVT, Toulouse, France.
Thibaut JammeLaboratoire de Biochimie et Biologie Moléculaire, Institut Fédératif de Biologie, CHU de Toulouse, Toulouse, France.
Jérôme AusseilLaboratoire de Biochimie et Biologie Moléculaire, Institut Fédératif de Biologie, CHU de Toulouse, Toulouse, France.
Didier ConcordetINTHERES, Université de Toulouse, INRAE, ENVT, Toulouse, France. didier.concordet@envt.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medical diagnostic processes often rely on comprehensive biological assessments, but current methods have drawbacks, such as insufficient consideration of variable dependence. Modern databases enable precise estimation of multidimensional variable distributions, prompting this study to enhance methodologies for biological variables. The focus is on establishing better reference regions and defining more accurate decision boundaries. Using an American database (1999-2017) with 19,231 healthy and 24,257 diseased individuals, the study examined plasma biochemical markers. The methodology involved constructing reference regions based on level sets of the healthy and diseased distributions and establishing decision boundaries. An example involved selecting diseased liver patients and considering 9 biological variables characterizing liver dysfunction. The proposed method is consistently more sensitive and specific than traditional approaches. Our results show that other biological functions, such as renal and cardiac functions, in a patient with liver dysfunction are also likely to be altered, even if the biochemical variables measuring these functions remain within the reference range. Therefore, it is preferable to consider a large panel of biological variables rather than just 9 to accurately characterize liver function. Despite potential limitations in identifying diseases, the proposed methodology provides valuable insights into physiological dysfunctions, enhancing early detection.

Indexed as

Liver DiseasesPrecision MedicineBiomarkersDatabases, FactualFemaleHumansMaleMiddle AgedReference ValuesBiomarkersAmerican databaseDiseased populationsEarly detectionHealthy populationMultidimensional decision boundariesReference regions

Identifiers

PMID40646054
PMCPMC12254216

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.